Integrated Network Pharmacology and Molecular Dynamics Reveal Multi-Target Anticancer Mechanisms of Myrtus communis

Ahmed Bayoudh1, Nidhal Tarhouni1, Riadh Ben Mansour2

  • 1Laboratory of Enzyme Engineering and Microbiology, Engineering National School of Sfax (ENIS), University of Sfax, P.O. Box 1173, Sfax 3038, Tunisia.

PubMed

Insights

Tunisian Myrtus communis essential oils (McEOs) show potent anticancer activity by targeting multiple pathways, with spathulenol acting as a strong Androgen Receptor antagonist, supporting potential for hormone-dependent cancers.

Area of Science:

  • Natural Product Chemistry
  • Computational Biology
  • Pharmacology

Background:

  • Cancer complexity necessitates polypharmacological strategies targeting multiple oncogenic pathways.
  • Natural products offer diverse chemical structures for multi-target drug discovery.
  • Myrtus communis essential oils (McEOs) possess potential for anticancer applications.

Purpose of the Study:

  • Investigate the anticancer mechanisms of Tunisian McEOs.
  • Elucidate the polypharmacological basis and therapeutic potential of McEOs.
  • Utilize an integrated computational-experimental framework.

Main Methods:

  • Gas Chromatography-Mass Spectrometry (GC-MS) for McEO composition analysis.
  • MTT assays for antiproliferative activity against HeLa, MCF-7, and Raji cancer cell lines.
  • Network pharmacology, molecular docking, and molecular dynamics simulations for mechanism elucidation.

Main Results:

  • McEOs are rich in 1,8-cineole and sesquiterpenes.
  • Demonstrated differential cytotoxicity: HeLa > MCF-7 > Raji.
  • Identified spathulenol as a high-affinity Androgen Receptor antagonist.
  • Confirmed spathulenol-AR complex stability via molecular dynamics.

Conclusions:

  • McEOs exert multi-target anticancer effects through synergistic interactions.
  • Spathulenol's potent Androgen Receptor antagonism contributes significantly to McEOs' activity.
  • Validated McEOs' therapeutic potential for hormone-dependent malignancies.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.0K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.6K